New York State Common Retirement Fund’s Genocea Biosciences, Inc. GNCA Stock Holding History

New York State Common Retirement Fund’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,800	Closed	-$32K	–	3269
2018 Q1	$32K	Hold	3,800	–	–	﹤0.01%	3051
2017 Q4	$35K	Hold	3,800	–	–	﹤0.01%	3059
2017 Q3	$44K	Hold	3,800	–	–	﹤0.01%	3066
2017 Q2	$159K	Buy	+3,800	New	+$183K	﹤0.01%	2958
2016 Q2	–	Sell	-2,513	Closed	-$156K	–	3227
2016 Q1	$156K	Hold	2,513	–	–	﹤0.01%	2783
2015 Q4	$106K	Hold	2,513	–	–	﹤0.01%	2997
2015 Q3	$138K	Buy	2,513 +898	+56%	+$89K	﹤0.01%	2936
2015 Q2	$177K	Buy	+1,615	New	+$150K	﹤0.01%	2960

Other funds holding GNCA

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

New York State Common Retirement Fund's GNCA Position: Q2 2018 in Review

New York State Common Retirement Fund sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2018, closing a stake of 3,800 shares — an estimated $32K sold.

New York State Common Retirement Fund first reported a position in GNCA in Q2 2015 and held it in 8 quarters. The position peaked at $177K in Q2 2015. 54 funds tracked by Wall St. Rank hold GNCA as of Q2 2018.

New York State Common Retirement Fund reported no remaining Genocea Biosciences, Inc. position as of Q2 2018 after selling out during the quarter.
New York State Common Retirement Fund sold 3,800 Genocea Biosciences, Inc. shares in Q2 2018, an estimated $32K.
New York State Common Retirement Fund first reported a position in Genocea Biosciences, Inc. in Q2 2015 and held it in 8 quarters.
New York State Common Retirement Fund's Genocea Biosciences, Inc. position peaked at $177K in Q2 2015.
54 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2018.

Based on New York State Common Retirement Fund's 13F filing for Q2 2018, filed 10 Aug 2018.